Pharmafile Logo

Patients’willingness to pay

Considerations when developing an appropriate pricing strategy in self-pay markets


When launching a new product, it’s critical that pharma chooses the right pricing strategy to achieve the optimal balance between sales volume and unit cost.

In emerging markets, pricing is made more sensitive by the fact that frequently a high proportion of healthcare costs are paid for out-of-pocket by consumers and their families, making them key decision makers. In the past, pricing models in emerging markets were often developed using patient affordability assumptions…Read the full article: https://bit.ly/2OOHMA0

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

A MERGER THAT MATTERS

Pegasus, Ashfield Digital and Creative and Cambridge Biomarketing relaunch as Mind+Matter     ‘First-in-class’ global agency conceived to confront the toughest challenges in healthcare and wellness   New global agency offers 24/7 access…

Webcast

The power of a good story: Turn your insights into effective storytelling with data visualisation

Article

How will COVID-19 affect uptake of vaccinations against other diseases?

Podcast

Living With Chronic Illness (Series one)

Webcast

China: How pharma can maximize success in this rapidly changing emerging market

Article

Inhale, Exhale: The struggle of living with Severe Asthma and Severe Eosinophilic Asthma

Infographic

Migraine market snapshot

Webcast

Monitoring the impact of COVID-19 on the market access landscape

Live webinar from Singapore

Digital #marcomms: How to evaluate and optimise marketing activities impacted by COVID-19

Guide

UX research